patent infringement
Illumina, Qiagen, Columbia University Near Settlement in Patent Infringement Case
It is unclear whether the impending settlement will affect all the litigation between the two sides, across several legal venues.
US Appeals Court Rejects Bio-Rad's 'Zombie' Claims to 10x Genomics' Single-Cell Patents
The ruling came as part of a decision to uphold a US International Trade Commission finding that Bio-Rad imported and sold infringing products.
US Appeals Court Upholds Invalidation of Columbia University Sequencing Chemistry Patents
The appellate court's decision deals a blow to a 2017 Columbia University lawsuit that alleged Illumina infringed one of the invalidated patents.
Natera Sues Inivata, Alleging Infringement of Cancer Testing Patents
Natera alleges Inivata infringes its US Patent Nos. 10,262,755 and 10,597,709, which cover cancer monitoring and molecular residual disease testing.
BGI Sues Illumina for Antitrust Violation, Claims Firm Obtained Sequencing Patents Through Fraud
In their complaint the plaintiffs claimed Illumina fraudulently obtained two US patents by concealing a reference from the patent office.